Beta Cell Preservation
COMING SOON
Reduce the trauma of an acute diagnosis for patients and families
Lower the incidence of diabetic ketoacidosis (DKA) at diagnosis in children with a genetic risk of T1D, who are then closely followed. Earlier identification can reduce the rate of DKA from 30% to 60% among patients who do not undergo early screening to less than 5% in screened populations.4 This is particularly important given that DKA at the onset of T1D is associated with increased mortality risk, longer hospitalizations, higher insulin requirements, shorter remission period, and worse glycemic control over time.3
Encourage caregivers to be more cognizant of clinical symptoms indicating T1D onset, leading to faster follow-up with healthcare providers
Provide time for patients and caregivers to learn about T1D and the lifestyle modifications required before clinical disease manifests
Identify patients for preventive therapies
Identify patients who may be eligible for clinical trials
As the table below shows, the results of the screening test determine an individual’s stage of diabetes.
References
- List
- list
- list
